The Baby and Me Tobacco Free Program (BMTFP) is developing and piloting a cannabis cessation module for pregnant people to address nicotine and cannabis co-use. The cannabis cessation module addresses a growing need in Colorado. Data from the Pregnancy Risk Assessment Monitoring System (PRAMS) indicate that combustible tobacco use is decreasing among pregnant people while use of vaped nicotine and cannabis is rising. Importantly, co-use of nicotine and cannabis among pregnant people is rising. Studies have shown that co-use of nicotine and cannabis may impede one’s ability to stop using nicotine, and may contribute to a higher risk of returning to use after cessation. Research shows that pregnant people may use cannabis products for many reasons, including the management of mental health symptoms (e.g., anxiety), pain, nausea, and/or pre-pregnancy use. In addition, cannabis and nicotine use (individual use or co-use) during pregnancy are highly correlated with traumatic stress. People with a history of traumatic stress are an underserved population that can benefit from a trauma-informed cessation approach provided by the BMTFP intervention.
The cannabis cessation module is focused on risk reduction. This model will be used to help pregnant people decrease or stop cannabis during their pregnancy and up to three months post-partum, and to support perinatal people in managing stress, anxiety, and other underlying conditions. The module does not have an official release date yet, but the program facilitators are motivated to make the program available to the public as soon as January 1, 2025. The pilot study of the cannabis cessation and co-use model will begin enrolling participants from Denver Health and University of Colorado Hospital in January 2025 with the goal to determine the efficacy of the program as well as collect process evaluation data to optimize the approach.
We are seeking individuals with lived experience with tobacco, vaped nicotine, or cannabis use before or during pregnancy for our advisory board. Participation is confidential and advisory group members will receive gift cards in recognition of their time and expertise. Any questions about participation can be directed to Theresa Anderson.
Additional guidance on addressing cannabis use during pregnancy and lactation.
|